Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_3
1
11%
Ph phase_2
2
22%
Ph not_applicable
4
44%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
4(57.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

9

all time

Status Distribution
Completed(4)
Terminated(2)
Other(3)

Detailed Status

Completed4
unknown3
Withdrawn1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (28.6%)
Phase 31 (14.3%)
N/A4 (57.1%)

Trials by Status

withdrawn111%
completed444%
unknown333%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9